Journal publications and book contributions
Publications in the last 5 years
| Derstroff M, Schmidt L, Mathes T et al. Guidelines and recommendations for preparing policy briefs from research into policy-making in health sciences: a scoping review. Syst Rev 2026. https://doi.org/10.1186/s13643-026-03090-4. |
| Lacombe D, Cardoso Borges F, Amariutei AE et al. Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum. J Cancer Policy 2026; 47: 100700. https://doi.org/10.1016/j.jcpo.2025.100700. |
| Paschen U, Sauerland S. Frameworks for assessing diagnostic interventions are useful for HTA work, but context-dependent. J Clin Epidemiol 2026; 189: 112106. https://doi.org/10.1016/j.jclinepi.2025.112106. |
| Schröer-Günther M, Zschorlich B, Siegert S et al. Einbindung von Betroffenenperspektiven im Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) mit Fokus auf die Erstellung von Gesundheitsinformationen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2026. https://doi.org/10.1007/s00103-026-04188-9. |
| Wieseler B, Preukschat D, Kranz P. Generating evidence that meets the requirements of both regulatory agencies and HTA bodies. Lancet Reg Health Eur 2026; 60: 101563. https://doi.org/10.1016/j.lanepe.2025.101563. |
| Amdal CD, Falk RS, Alanya A et al. SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials. Lancet Oncol 2025; 26(12): e683-e693. https://doi.org/10.1016/S1470-2045(25)00520-0. |
| Bender R, Beckmann L. Hazards, Causality, and Practical Relevance of Collider Effects - Comment on Beyersmann et al. "Hazards Constitute Key Quantities for Analyzing, Interpreting and Understanding Time-to-Event Data". Biom J 2025; 67(5): e70071. https://doi.org/10.1002/bimj.70071. |
| Köhler M, Paul F, Janke K et al. Comparative effectiveness of disease-modifying therapies for highly active relapsing-remitting multiple sclerosis despite previous treatment - a systematic review and network meta-analysis. BMC Neurol 2025; 25(1): 328. https://doi.org/10.1186/s12883-025-04338-7. |
| Merlin T, Werko SS, Rüther A et al. Celebrating 30 years of the international network of agencies for health technology assessment (INAHTA). Int J Technol Assess Health Care 2025; 41(1): e7. https://doi.org/10.1017/S0266462325000042. |
| Mikael S, Sauerland S. Methodological flaws in study on transurethral holmium laser enucleation. Langenbecks Arch Surg 2025; 410(94). https://doi.org/10.1007/s00423-025-03628-5. |
| Pe M, Voltz-Girolt C, Bell J et al. Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop. Lancet Oncol 2025; 26(6): 687-690. https://doi.org/10.1016/S1470-2045(25)00150-0. |
| Preukschat D, Meller S. Studienendpunkte in der frühen Nutzenbewertung aus Sicht des IQWiG [online]. 2025 [Zugriff: 07.05.2025]. URL: https://www.aerztezeitung.de/Dateien/Welche-Endpunkte-sind-patientenrelevant-d-909.pdf. |
| Schröer-Günther M, Koch K, Scheike I. Taking a look behind the scenes: Updating health information on Gesundheitsinformation.de. Z Evid Fortbild Qual Gesundhwes 2025. https://doi.org/10.1016/j.zefq.2025.04.002. |
| Selbach C, Siebel C, Lilienthal J et al. Weaning from tobacco with nicotine or varenicline in severe and mild tobacco dependence—findings of a meta-analysis. Dtsch Arztebl Int 2025; 122: 7-11. https://doi.org/10.3238/arztebl.m2024.0223. |
| Siemens W, von Elm E, Binder H et al. Opportunities, challenges and risks of using artificial intelligence for evidence synthesis. BMJ Evid Based Med 2025. https://doi.org/10.1136/bmjebm-2024-113320. |
| Spix B, Preukschat D. IQWiG-Methoden-Papier und EU-Guidances: Ein Vergleich [online]. 2025 [Zugriff: 14.10.2025]. URL: https://www.aerztezeitung.de/Dateien/EU-Pharma-Regulierung-Impulse-fuer-Deutschland-d-953.pdf. |
| Wieseler B, Skavron R. EU-Health Technology Assessment (EU-HTA) und seine Perspektiven für die zukünftige Bewertung von Gesundheitstechnologien [online]. 2025 [Zugriff: 04.03.2026]. URL: https://doi.org/10.1007/978-3-662-72460-6_7. |
| Interview mit Dr. Anja Schwalm, IQWiG-Bereichsleitung Gesundheitsökonomie, für Gesundheitsökonomie und Qualitätsmanagement. Gesundheitsökonomie und Qualitätsmanagement 2024; 29(01): 20-21. https://doi.org/10.1055/a-2182-5088. |
| Bognanni A, Fiocchi A, Arasi S et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XII - Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA. World Allergy Organ J 2024; 17(4): 100888. https://doi.org/10.1016/j.waojou.2024.100888. |
| Bognanni A, Firmino RT, Arasi S et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic review. World Allergy Organ J 2024; 17(9): 100947. https://doi.org/10.1016/j.waojou.2024.100947. |
| Büchter RB, Albrecht M, Grimm M et al. Inhaltliche Weiterentwicklung von Standards zur Erstellung evidenzbasierter Gesundheitsinformationen: Eine Bedarfserhebung und Priorisierung im EbM-Netzwerk. Z Evid Fortbild Qual Gesundhwes 2024. https://doi.org/10.1016/j.zefq.2024.03.011. |
| Endres D, Gowik J, Tasar A. IQWiG-Evidenzbericht zum Thema psychische Folgen eines Schwangerschaftsabbruchs. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2024. https://doi.org/10.1007/s00103-024-03993-4. |
| Goldkuhle M, Hirsch C, Iannizzi C et al. Exploring the characteristics, methods and reporting of systematic reviews with meta-analyses of time-to-event outcomes: a meta-epidemiological study. BMC Med Res Methodol 2024; 24(1): 291. https://doi.org/10.1186/s12874-024-02401-4. |
| Großhennig A, Bender R, Leverkus F. Praktische Aspekte bei der Anwendung von Propensity Scores. GMS Med Inform Biom Epidemiol 2024; 20: 05. https://doi.org/10.3205/mibe000261. |
| Hausner E, Sturtz S, Molnar S et al. Searching for non-English literature may be unnecessary for German HTA Reports. F1000Res 2024; 13: 1134. https://doi.org/10.12688/f1000research.151365.2. |
| Kaiser T, Vervoelgyi V. Anwendungsbegleitende Datenerhebungen für die Nutzenbewertung von Arzneimitteln in Deutschland: Warum, wann und wie? GMS Med Inform Biom Epidemiol 2024; 20: Doc04. https://doi.org/10.3205/mibe000260. |
| Kapp C, Fujita-Rohwerder N, Lilienthal J et al. The searchbuildR shiny app: A new implementation of the objective approach for search strategy development in systematic reviews. Cochrane Evidence Synthesis and Methods 2024; 2(6): e12078. https://doi.org/10.1002/cesm.12078. |
| Kranz P, McGauran N, Unal C et al. Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs. Int J Technol Assess Health Care 2024; 40(1): e68. https://doi.org/10.1017/S026646232400062X. |
| Lilienthal J, Sturtz S, Schürmann C et al. Bayesian random-effects meta-analysis with empirical heterogeneity priors for application in health technology assessment with very few studies. Res Synth Methods 2024; 15(2): 275-287. https://doi.org/10.1002/jrsm.1685. |
| Sauerland S. Das zähe Ringen um ein Screening; Einschätzung. Dtsch Arztebl 2024; 121(6): A383. |
| Schmidt L, Hair K, Graziozi S et al. Exploring the use of a Large Language Model for data extraction in systematic reviews: a rapid feasibility study. CEUR Workshop Proceedings 2024; 3832. |
| Schröter M, Cramer H, Haller H et al. Yoga as Potential Therapy for Burnout: Health Technology Assessment Report on Efficacy, Safety, Economic, Social, Ethical, Legal and Organizational Aspects. Curr Psychiatry Rep 2024. https://doi.org/10.1007/s11920-024-01516-1. |
| Seidel DH, Markes M, Grouven U et al. Systemic therapy in children and adolescents with mental disorders: a systematic review and meta-analysis. BMC Psychiatry 2024; 24(1): 125. https://doi.org/10.1186/s12888-024-05556-y. |
| Urbina I, Adams R, Fernandez J et al. Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA. Int J Technol Assess Health Care 2024; 40(1): e75. https://doi.org/10.1017/S0266462324004689. |
| Büchter RB, Koch K. Evidenzbasierte Gesundheitsinformationen. In: Schwartz FW, Walter U, Siegrist J et al (Ed). Public Health: Gesundheit und Gesundheitswesen. München: Elsevier; 2023. S. 501-506. |
| Felgenträger K, Waffenschmidt S. Methoden des Information Retrievals zur systematischen Literaturanalyse. In: Perleth M, Busse R, Fuchs S et al (Ed). Health Technology Assessment; Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2023. S. 147-173. |
| Fuchs S, Behring A, Rüther A, Perleth M. Entwicklung von HTA in Europa und international. In: Perleth M, Busse R, Fuchs S et al (Ed). Health Technology Assessment; Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2023. S. 105-119. |
| Goldkuhle M, Hirsch C, Iannizzi C et al. Meta-epidemiological review identified variable reporting and handling of time-to-event analyses in publications of trials included in meta-analyses of systematic reviews. J Clin Epidemiol 2023; 159(159): 174-189. https://doi.org/10.1016/j.jclinepi.2023.05.023. |
| Großelfinger R. Feststellung des Unabhängigkeitsstatus für HTA-Einrichtungen. In: Perleth M, Busse R, Fuchs S et al (Ed). Health Technology Assessment; Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2023. S. 99-104. |
| Kapp C, Fujita-Rohweder N, Sieben W et al. Implementation of a text analysis process using R for search strategy development in systematic reviews: Protocol. Zenodo 2023. https://doi.org/10.5281/zenodo.7762286. |
| King-Kallimanis BL, Calvert M, Cella D et al. Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials. Value Health 2023; 26(10): 1543-1548. https://doi.org/10.1016/j.jval.2023.06.019. |
| Klerings I, Robalino S, Booth A et al. Rapid reviews methods series: Guidance on literature search. BMJ Evid Based Med 2023. https://dx.doi.org/10.1136/bmjebm-2022-112079. |
| Kranz P, McGauran N, Banzi R et al. Rapid response to: Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases (BMJ 2023;381:e072796) [online]. 2023 [Zugriff: 24.07.2023]. URL: https://www.bmj.com/content/381/bmj-2022-072796/rr-0. |
| Kranz P, McGauran N, Banzi R et al. Rapid response to: Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases (BMJ 2023;381:e072796) [online]. 2023 [Zugriff: 18.10.2023]. URL: https://www.bmj.com/content/381/bmj-2022-072796/rr-3. |
| Kranz P, McGauran N, Banzi R et al. Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases. BMJ 2023; 381(e072796): e072796. https://doi.org/10.1136/bmj-2022-072796. |
| Lühmann D, Rüther A, Perleth M. Grundlagen und Prinzipien von Health Technology Assessment (HTA). In: Perleth M, Busse R, Fuchs S et al (Ed). Health Technology Assessment; Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2023. S. 1-48. |
| Röver C, Sturtz S, Lilienthal J et al. Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis. Stat Med 2023. https://dx.doi.org/10.1002/sim.9731. |
| Sauerland S, Langenbach MR. Managing symptomatic gallstone disease. BMJ 2023; 383: 2624. https://doi.org/10.1136/bmj.p2624. |
| Schmucker C, Thorel E, Flatscher-Thoni M et al. Computer-Assisted Visual Training in Children and Adolescents with Developmental Visual Disorders. Dtsch Arztebl Int 2023; 120(44): 747-753. https://doi.org/10.3238/arztebl.m2023.0191. |
| Veit C, Bierbaum T, Wesselmann S et al. Versorgungsnahe Daten für Versorgungsanalysen – Teil 3 des Manuals. Gesundheitswesen 2023; 85(08/09): 718-724. https://doi.org/10.1055/a-1966-0104. |
| Vervölgyi V, Kaiser T. Datenerhebungen zu Arzneimitteln – eine Perspektive für die Krebsregister. Onkologie 2023; 30(4): 289-295. https://doi.org/10.1007/s00761-023-01443-5. |
| Waffenschmidt S, Bender R. Involvement of information specialists and statisticians in systematic reviews. Int J Technol Assess Health Care 2023; 39(1): e22. https://dx.doi.org/10.1017/S026646232300020X. |
| Waffenschmidt S, Sieben W, Jakubeit T et al. Increasing the efficiency of study selection for systematic reviews using prioritization tools and a single-screening approach. Syst Rev 2023; 12(1): 161. https://doi.org/10.1186/s13643-023-02334-x. |
| Wieseler B. Patients need better treatments, not just more of the same. BMJ 2023; 382: 1466. https://doi.org/10.1136/bmj.p1466. |
| Wieseler B, Neyt M, Kaiser T et al. Authors' reply to Morales and Arlett. BMJ 2023; 381: 740. https://doi.org/10.1136/bmj.p740. |
| Wieseler B, Neyt M, Kaiser T et al. Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy? BMJ 2023; 380: e073100. https://dx.doi.org/10.1136/bmj-2022-073100. |
| Wieseler B, Neyt M, Kaiser T et al. Replacing RCTs with real world data for regulatory decision making; Authors’ reply to Morales and Arlett. BMJ 2023; 381: p740. https://doi.org/10.1136/bmj.p740 |
| Zschorlich B, Wiegard B, Warthun N, Koch K. Health information for hard-to-reach target groups: A qualitative needs assessment. Z Evid Fortbild Qual Gesundhwes 2023; 179: 8-17. https://doi.org/10.1016/j.zefq.2023.03.012. |
| Bognanni A, Chu DK, Firmino RT et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XIII - Oral immunotherapy for CMA - Systematic review. World Allergy Organ J 2022; 15(9): 100682. https://doi.org/10.1016/j.waojou.2022.100682. |
| Brozek JL, Firmino RT, Bognanni A et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapy. World Allergy Organ J 2022; 15(4): 100646. https://dx.doi.org/10.1016/j.waojou.2022.100646. |
| Felsch M, Beckmann L, Bender R et al. Performance of several types of beta-binomial models in comparison to standard approaches for meta-analyses with very few studies. BMC Med Res Methodol 2022; 22(1): 319. https://dx.doi.org/10.1186/s12874-022-01779-3. |
| Forster J, Sauerland S. Fieber senken bei Kindern und Erwachsenen: Ab wann ist es sinnvoll? KVH Journal 2022; (11): 22-24. |
| Fujita-Rohwerder N. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume((R)) Drug-Coated Balloon for Anterior Urethral Strictures. Letter. J Urol 2022; 207(4): 941-942. https://dx.doi.org/10.1097/JU.0000000000002426. |
| Fujita-Rohwerder N, Beckmann L, Zens Y et al. Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis. BMJ Evid Based Med 2022. https://dx.doi.org/10.1136/bmjebm-2021-111828. |
| Hausner E, Knelangen M, Waffenschmidt S. Use of text mining tools in the development of search strategies - Comparison of different approaches. J Clin Epidemiol 2022. https://dx.doi.org/10.1016/j.jclinepi.2022.05.011. |
| Jakubeit T, Sturtz S, Sow D et al. Single-fraction stereotactic radiosurgery versus microsurgical resection for the treatment of vestibular schwannoma: a systematic review and meta-analysis. Syst Rev 2022; 11: 265. https://dx.doi.org/10.1186/s13643-022-02118-9. |
| Janke K, Kiefer C, McGauran N et al. A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis. BMC Rheumatol 2022; 6: 82. https://dx.doi.org/10.1186/s41927-022-00314-7. |
| Karam S, Darzi AJ, Bognanni A et al. Analytical Frameworks in Colorectal Cancer Guidelines: Development of Methods for Systematic Reviews, their Application and Practical Guidance for their use. J Clin Epidemiol 2022. https://dx.doi.org/10.1016/j.jclinepi.2022.06.005. |
| Klinkhammer-Schalke M, Wesselmann S, Bruns J et al. Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung; Übersichtsarbeit. Gesundheitswesen 2022. https://dx.doi.org/10.1055/a-1926-6818. |
| Lange S. Grundlagen und Methoden einer versorgungsnahen Datenerhebung [online]. 2022 [Zugriff: 02.05.2023]. URL: https://www.aerztezeitung.de/Dateien/Weiterentwicklung-des-AMNOG-mit-Augenmass-u-Evidenz-d-570.pdf. |
| Lange S, Lauterberg J. Pragmatischere randomisierte Studien mit Fokus auf Registerbasierung. Präv Gesundheitsf 2022. https://dx.doi.org/10.1007/s11553-022-00974-w. |
| Naumann-Winter F, Kaiser T, Behring A. Evidenzbasierte Arzneimittelversorgung bei Seltenen Erkrankungen: die Rolle der Digitalisierung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2022; 65: 1170-1177. https://dx.doi.org/10.1007/s00103-022-03605-z. |
| Paschen U, Sturtz S, Fleer D et al. Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care. BJU Int 2022; 129(3): 280-289. https://dx.doi.org/10.1111/bju.15444. |
| Ruether A, Imaz-Iglesia I, Belorgey C et al. European collaboration on health technology assessment: looking backward and forward. Int J Technol Assess Health Care 2022; 38(1): e34. https://dx.doi.org/10.1017/S026646232200006X. |
| Runkel B, Sauerland S. Screeningtests bei Schwangeren und Neugeborenen; Wissenschaftliche Voraussetzungen und praktische Umsetzung. Pädiatrische Praxis 2022; 97(3): 373–384. |
| Sauerland S. Einfaches Suchen in MEDLINE: Tipps und Tricks. KVH Journal 2022; (7-8): 26-29. |
| Schröer-Gunther M, Koch K. Die informierte Entscheidung als Ziel von evidenzbasierten Gesundheitsinformationen: Das Beispiel Krebsfrüherkennung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022; 65(5): 559-566. https://doi.org/10.1007/s00103-022-03526-x. |
| Schulz AS, C., Skipka G, Bender R. Performing Meta-analyses with Very Few Studies. In: Evangelou E, Veroniki AA (Ed). Meta-Research; Methods and Protocols. New York: Humana; 2022. S. 91-102. |
| Veit C, Bierbaum T, Wesselmann S et al. Versorgungsnahe Daten für Versorgungsanalysen – Teil 3 des Manuals. Gesundheitswesen 2022. https://dx.doi.org/10.1055/a-1966-0104. |
| Wieseler B. Covid-19 vaccines: individual patient data should be submitted to the European Medicines Agency. BMJ 2022; 376: o417. https://dx.doi.org/10.1136/bmj.o417. |